Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 30 results.
User Information
Export Records
  1. 1.   Loss of Brca1 and Trp53 in adult mouse mammary ductal epithelium results in development of hormone receptor-positive or hormone receptor-negative tumors, depending on inactivation of Rb family proteins
  2. Szabova,Ludmila; Gordon, Melanie B; Lu, Lucy; Pate, Nathan; Bassel,Laura; Iacovelli, Anthony J; Karim,Baktiar; Homan, Philip J; Householder,Deborah; Guerin,Theresa; Burkett,Sandra; Day,Amanda; Custer Lawrence,Wendi; Ohler,Zoe
  3. Breast Cancer Research : BCR. 2022, Nov 04; 24(1): 75.
  1. 2.   A phase 1 and pharmacodynamic study of chronically-dosed, single-agent veliparib (ABT-888) in patients with BRCA1- or BRCA2-mutated cancer or platinum-refractory ovarian or triple-negative breast cancer
  2. Manzo, Julia; Puhalla, Shannon; Pahuja, Shalu; Ding, Fei; Lin, Yan; Appleman, Leonard; Tawbi, Hussein; Stoller, Ronald; Lee, James J; Diergaarde, Brenda; Kiesel, Brian F; Yu, Jing; Tan, Antoinette R; Belani, Chandra P; Chew, Helen; Garcia, Agustin A; Morgan, Robert J; Wahner Hendrickson, Andrea E; Visscher, Daniel W; Hurley, Rachel M; Kaufmann, Scott H; Swisher, Elizabeth M; Oesterreich, Steffi; Katz, Tiffany; Ji,Jay; Zhang, Yiping; Parchment, Ralph E; Chen, Alice; Duan, Wenrui; Giranda, Vincent; Shepherd, Stacie P; Ivy, S Percy; Chu, Edward; Beumer, Jan H
  3. Cancer Chemotherapy and Pharmacology. 2022, Apr 18; 89(5): 721-735.
  1. 3.   Germline variants in hereditary breast cancer genes are associated with early age at diagnosis and family history in Guatemalan breast cancer
  2. Ren, Megan; Orozco, Anali; Shao, Kang; Albanez, Anaseidy; Ortiz, Jeremy; Cao, Boyang; Wang, Lusheng; Barreda, Lilian; Alvarez, Christian S.; Garland,Lisa; Wu,Dongjing; Chung,Charles; Wang,Jiahui; Frone, Megan; Ralon, Sergio; Argueta, Victor; Orozco, Roberto; Gharzouzi, Eduardo; Dean, Michael
  3. Breast cancer research and treatment. 2021, Jul 1;
  1. 4.   BRCA1 promoter hypermethylation in human placenta: A hidden link with ß-hCG expression
  2. Nadhan, Revathy; Vaman, Jayashree V; Sengodan,Satheesh; Hemalatha, Sreelatha K; Nirmala, C; Sadasivan, Santha; Aysha, P V; Yesodharan, Sreelekha; Krishnapriya, R S; Amritha Krishna, B V; P S, Sreevidya; Rajan, Arathi; Rajan Latha, Neetha; Varghese, Geetu Rose; Thankappan, Ratheeshkumar; Achyutuni, Sarada; Jithin, Dev S U; Anil Kumar, T V; Srinivas, Priya
  3. Carcinogenesis. 2020, MAY; 41(5): 611-624.
  1. 5.   RAD52 S346X Variant Reduces Breast Cancer Risk in BRCA2 Mutation Carriers
  2. Biswas,Kajal; Sharan,Shyam
  3. Molecular oncology. 2020, Apr 07;
  1. 6.   Sensitivity of mesothelioma cells to PARP inhibitors is not dependent on BAP1 but is enhanced by temozolomide in cells with high-Schlafen 11and low-MGMT expression
  2. Rathkey, Daniel; Khanal, Manakamana; Murai, Junko; Zhang, Jingli; Sengupta, Manjistha; Jiang, Qun; Morrow, Betsy; Evans,Christine; Chari,Raj; Fetsch, Patricia; Chung, Hye-Jung; Xi, Liqiang; Roth, Mark; Filie, Armando; Raffeld, Mark; Thomas, Anish; Pommier, Yves; Hassan, Raffit
  3. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2020, Jan 28; pii: S1556-0864(20)30035-6.
  1. 7.   ß-hCG induced mutant BRCA1 ignites drug resistance in susceptible breast tissue
  2. Sengodan,Satheesh; Hemalatha, Sreelatha K; Nadhan, Revathy; Somanathan, Thara; Mathew, Arun Peter; Chil, Arkadiusz; Kopczynski, Janusz; Nair, Rakesh Sathish; Kumar, Jerald Mahesh; Srinivas, Priya
  3. Carcinogenesis. 2019, Nov; 40(11): 1415-1426.
  1. 8.   A Recurrent BRCA2 Mutation Explains the Majority of Hereditary Breast and Ovarian Cancer Syndrome Cases in Puerto Rico
  2. Diaz-Zabala, Hector J; Ortiz, Ana P; Garland, Lisa; Jones, Kristine; Perez, Cynthia M; Mora, Edna; Arroyo, Nelly; Oleksyk, Taras K; Echenique, Miguel; Matta, Jaime L; Dean, Michael; Dutil, Julie
  3. Cancers. 2018, Nov 02; 10(11): pii: E419.
  1. 9.   Prevalence and spectrum of germline rare variants in BRCA1/2 and PALB2 among breast cancer cases in Sarawak, Malaysia
  2. Yang, Xiaohong R; Devi, Beena C R; Sung, Hyuna; Guida, Jennifer; Mucaki, Eliseos J; Xiao, Yanzi; Best, Ana; Garland, Lisa; Xie, Yi; Hu, Nan; Rodriguez-Herrera, Maria; Wang, Chaoyu; Jones, Kristine; Luo, Wen; Hicks, Belynda; Tang, Tieng Swee; Moitra, Karobi; Rogan, Peter K; Dean, Michael
  3. Breast Cancer Research and Treatment. 2017, Oct; 165: 687-697.
  1. 10.   Next Generation Sequencing Reveals High Prevalence of BRCA1 and BRCA2 Variants of Unknown Significance in Early-Onset Breast Cancer in African American Women.
  2. Ricks-Santi, Luisel; McDonald, J Tyson; Gold, Bert; Dean, Michael; Thompson, Nicole; Abbas, Muneer; Wilson, Bradford; Kanaan, Yasmine; Naab, Tammey J; Dunston, Georgia
  3. Ethnicity & disease. 2017, Apr 20; 27(2): 169-178.
  1. 11.   Plumbagin, a naphthaquinone derivative induces apoptosis in BRCA 1/2 defective castrate resistant prostate cancer cells as well as prostate cancer stem-like cells
  2. Reshma, R. S.; Sreelatha, K. H.; Somasundaram, V.; Satheesh Kumar, S.; Nadhan, R.; Nair, R. S.; Srinivas, P.
  3. Pharmacological Research. 2016, Mar; 105: 134-45.
  1. 12.   Yin Yang 1 positively regulates BRCA1 and inhibits mammary cancer formation
  2. Lee, M. H.; Lahusen, T.; Wang, R. H.; Xiao, C.; Xu, X.; Hwang, Y. S.; He, W. W.; Shi, Y.; Deng, C. X.
  3. Oncogene. 2012, Jan; 31(1): 116-127.
  1. 13.   CHEK2 genomic and proteomic analyses reveal genetic inactivation or endogenous activation across the 60 cell lines of the US National Cancer Institute
  2. Zoppoli, G.; Solier, S.; Reinhold, W. C.; Liu, H.; Connelly, J. W.; Monks, A.; Shoemaker, R. H.; Abaan, O. D.; Davis, S. R.; Meltzer, P. S.; Doroshow, J. H.; Pommier, Y.
  3. Oncogene. 2012, Jan; 31(4): 403-418.
  1. 14.   X-ray structures of checkpoint kinase 2 in complex with inhibitors that target its gatekeeper-dependent hydrophobic pocket
  2. Lountos, G. T.; Jobson, A. G.; Tropea, J. E.; Self, C. R.; Zhang, G. T.; Pommier, Y.; Shoemaker, R. H.; Waugh, D. S.
  3. Febs Letters. 2011, Oct; 585(20): 3245-3249.
  1. 15.   Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer
  2. Gaudet, M. M.; Kirchhoff, T.; Green, T.; Vijai, J.; Korn, J. M.; Guiducci, C.; Segre, A. V.; McGee, K.; McGuffog, L.; Kartsonaki, C.; Morrison, J.; Healey, S.; Sinilnikova, O. M.; Stoppa-Lyonnet, D.; Mazoyer, S.; Gauthier-Villars, M.; Sobol, H.; Longy, M.; Frenay, M.; Hogervorst, F. B. L.; Rookus, M. A.; Collee, J. M.; Hoogerbrugge, N.; van Roozendaal, K. E. P.; Piedmonte, M.; Rubinstein, W.; Nerenstone, S.; Van Le, L.; Blank, S. V.; Caldes, T.; de la Hoya, M.; Nevanlinna, H.; Aittomaki, K.; Lazaro, C.; Blanco, I.; Arason, A.; Johannsson, O. T.; Barkardottir, R. B.; Devilee, P.; Olopade, O. I.; Neuhausen, S. L.; Wang, X. S.; Fredericksen, Z. S.; Peterlongo, P.; Manoukian, S.; Barile, M.; Viel, A.; Radice, P.; Phelan, C. M.; Narod, S.; Rennert, G.; Lejbkowicz, F.; Flugelman, A.; Andrulis, I. L.; Glendon, G.; Ozcelik, H.; Tol, A. E.; Montagna, M.; D'Andrea, E.; Friedman, E.; Laitman, Y.; Borg, A.; Beattie, M.; Ramus, S. J.; Domchek, S. M.; Nathanson, K. L.; Rebbeck, T.; Spurdle, A. B.; Chen, X. Q.; Holl, H.; John, E. M.; Hopper, J. L.; Buys, S. S.; Daly, M. B.; Southey, M. C.; Terry, M. B.; Tung, N.; Hansen, T. V. O.; Nielsen, F. C.; Greene, M. I.; Mai, P. L.; Osorio, A.; Duran, M.; Andres, R.; Benitez, J.; Weitzel, J. N.; Garber, J.; Hamann, U.; Peock, S.; Cook, M.; Oliver, C.; Frost, D.; Platte, R.; Evans, D. G.; Lalloo, F.; Eeles, R.; Izatt, L.; Walker, L.; Eason, J.; Barwell, J.; Godwin, A. K.; Schmutzler, R. K.; Wappenschmidt, B.; Engert, S.; Arnold, N.; Gadzicki, D.; Dean, M.; Gold, B.; Klein, R. J.; Couch, F. J.; Chenevix-Trench, G.; Easton, D. F.; Daly, M. J.; Antoniou, A. C.; Altshuler, D. M.; Offit, K.; kConFab, G. S. C. H. S. C. O.
  3. Plos Genetics. 2010, Oct; 6(10): 12.
  1. 16.   Expression of human BRCA1 variants in mouse ES cells allows functional analysis of BRCA1 mutations
  2. Chang, S.; Biswas, K.; Martin, B. K.; Stauffer, S.; Sharan, S. K.
  3. Journal of Clinical Investigation. 2009, Oct; 119(10): 3160-71.
  1. 17.   Cadmium Malignantly Transforms Normal Human Breast Epithelial Cells into a Basal-like Phenotype
  2. Benbrahim-Tallaa, L.; Tokar, E. J.; Diwan, B. A.; Dill, A. L.; Coppin, J. F.; Waalkes, M. P.
  3. Environmental Health Perspectives. 2009 117(12): 1847-1852.
  1. 18.   Long-term BRCA1 down-regulation by small hairpin RNAs targeting the 3 ' untranslated region
  2. Vondruskova, E.; Malik, R.; Sevcik, J.; Kleiblova, P.; Kleibl, Z.
  3. Neoplasma. 2008 55(2): 130-137.
  1. 19.   Network modeling links breast cancer susceptibility and centrosome dysfunction
  2. Pujana, M. A.; Han, J. D. J.; Starita, L. M.; Stevens, K. N.; Tewari, M.; Ahn, J. S.; Rennert, G.; Moreno, V.; Kirchhoff, T.; Gold, B.; Assmann, V.; ElShamy, W. M.; Rual, J. F.; Levine, D.; Rozek, L. S.; Gelman, R. S.; Gunsalus, K. C.; Greenberg, R. A.; Sobhian, B.; Bertin, N.; Venkatesan, K.; Ayivi-Guedehoussou, N.; Sole, X.; Hernandez, P.; Lazaro, C.; Nathanson, K. L.; Weber, B. L.; Cusick, M. E.; Hill, D. E.; Offit, K.; Livingston, D. M.; Gruber, S. B.; Parvin, J. D.; Vidal, M.
  3. Nature Genetics. 2007, Nov; 39(11): 1338-1349.
  1. 20.   BRCA1a has antitumor activity in TN breast, ovarian and prostate cancers
  2. Yuli, C.; Shao, N.; Rao, R.; Aysola, P.; Reddy, V.; Oprea-llies, G.; Lee, L.; Okoli, J.; Partridge, E.; Reddy, E. S. P.; Rao, V. N.
  3. Oncogene. 2007, Sep; 26(41): 6031-6037.
  1. 21.   A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer
  2. Hunter, D. J.; Kraft, P.; Jacobs, K. B.; Cox, D. G.; Yeager, M.; Hankinson, S. E.; Wacholder, S.; Wang, Z. M.; Welch, R.; Hutchinson, A.; Wang, J. W.; Yu, K.; Chatterjee, N.; Orr, N.; Willett, W. C.; Colditz, G. A.; Ziegler, R. G.; Berg, C. D.; Buys, S. S.; McCarty, C. A.; Feigelson, H. S.; Calle, E. E.; Thun, M. J.; Hayes, R. B.; Tucker, M.; Gerhard, D. S.; Fraumeni, J. F.; Hoover, R. N.; Thomas, G.; Chanock, S. J.
  3. Nature Genetics. 2007, Jul; 39(7): 870-874.
  1. 22.   C/EBP delta is a crucial regulator of pro-apoptotic gene expression during mammary gland involution
  2. Thangaraju, M.; Rudelius, M.; Bierie, B.; Raffeld, M.; Sharan, S.; Hennighausen, L.; Huang, A. M.; Sterneck, E.
  3. Development. 2005, NOV; 132(21): 4675-4685.
  1. 23.   Estrogen receptor genotypes and haplotypes associated with breast cancer risk
  2. Gold, B.; Kalush, F.; Bergeron, J.; Scott, K.; Mitra, N.; Wilson, K.; Ellis, N.; Huang, H.; Chen, M.; Lippert, R.; Halldorsson, B. V.; Woodworth, B.; White, T.; Clark, A. G.; Parl, F. F.; Broder, S.; Dean, M.; Offit, K.
  3. Cancer Research. 2004, DEC 15; 64(24): 8891-8900.
  1. 24.   In vivo functional analysis of missense mutations in BRCA1 using humanized mouse models
  2. Yang, Y. P.; Martin, B. K.; Sharan, S. K.
  3. Cancer Epidemiology Biomarkers & Prevention. 2004, NOV; 13(11, Part 2): 1837S-1837S.
  1. 25.   Transcriptional coregulator SNURF (RNF4) possesses ubiquitin E3 ligase activity
  2. Hakli, M.; Lorick, K. L.; Weissman, A. M.; Janne, O. A.; Palvimo, J. J.
  3. Febs Letters. 2004 560(1-3): 56-62.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel